IMRX - Immuneering Corporation - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-30.13M

Cash

71.28M

Avg Qtr Burn

-12.51M

Short % of Float

16.51%

Insider Ownership

29.15%

Institutional Own.

34.82%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IMM-1-104 Details Solid tumor/s	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
IMM-6-415 Details Solid tumor/s	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.